AZGP1 anticorps (N-Term)
Aperçu rapide pour AZGP1 anticorps (N-Term) (ABIN634659)
Antigène
Voir toutes AZGP1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- AZGP1 antibody was raised against the N terminal of AZGP1
-
Purification
- Affinity purified
-
Immunogène
- AZGP1 antibody was raised using the N terminal of AZGP1 corresponding to a region with amino acids KVAQYMADVLEDSKDKVQENLLANGVDLVTYITRFQWDMAKYPIKQSLKN
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
AZGP1 Blocking Peptide, (ABIN940086), is also available for use as a blocking control in assays to test for specificity of this AZGP1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of AZGP1 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- AZGP1 (alpha-2-Glycoprotein 1, Zinc-Binding (AZGP1))
-
Autre désignation
- AZGP1
-
Sujet
- Stimulates lipid degradation in adipocytes and causes the extensive fat losses associated with some advanced cancers. AZGP1 may bind polyunsaturated fatty acids.
-
Poids moléculaire
- 33 kDa (MW of target protein)
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
Antigène
-